Dr. Richard Smith, a local neurologist and director of the Center for Neurologic Study in La Jolla, told the Union-Tribune that the pathway for this new drug was etched a decade ago and was met with some skepticism initially. He stated that the “point that has drawn the most skepticism from peers has always been drug delivery.” This article can be found here.

The San Diego Union-Tribune featured the drug discovery efforts of CNS director Dr. Smith and his colleagues, Don Cleveland (UCSD) and Frank Bennett (Ionis Pharmaceuticals), in a recently published article entitled "Designer DNA drugs approach a potential watershed moment".

The Journal Nature Outlook published an article highlighting Dr. Smith and the Center for Neurologic Study's work on Nuedexta. This can be found here.